Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 613584, 12 pages
http://dx.doi.org/10.1155/2015/613584
Research Article

Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice

1College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
2National First-Class Key Discipline for Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
3Zhejiang Chinese Medical University, Hangzhou 310053, China
4Nanjing Municipal Hospital of TCM, Nanjing 210001, China

Received 6 December 2014; Revised 6 April 2015; Accepted 6 April 2015

Academic Editor: Youn C. Kim

Copyright © 2015 Ping Qiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Altamirano and R. Bataller, “Alcoholic liver disease: pathogenesis and new targets for therapy,” Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 9, pp. 491–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Levene and R. D. Goldin, “The epidemiology, pathogenesis and histopathology of fatty liver disease,” Histopathology, vol. 61, no. 2, pp. 141–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Rasineni and C. A. Casey, “Molecular mechanism of alcoholic fatty liver,” Indian Journal of Pharmacology, vol. 44, no. 3, pp. 299–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Hu, F. Wang, X. Li et al., “Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice,” Hepatology, vol. 55, no. 2, pp. 437–446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. You, M. Matsumoto, C. M. Pacold, W. K. Cho, and D. W. Crabb, “The role of AMP-activated protein kinase in the action of ethanol in the liver,” Gastroenterology, vol. 127, no. 6, pp. 1798–1808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. H. Tan, D. H. G. Crawford, L. A. Jaskowski et al., “A corn oil-based diet protects against combined ethanol and iron-induced liver injury in a mouse model of hemochromatosis,” Alcoholism: Clinical and Experimental Research, vol. 37, no. 10, pp. 1619–1631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Purohit, B. Gao, and B.-J. Song, “Molecular mechanisms of alcoholic fatty liver,” Alcoholism: Clinical and Experimental Research, vol. 33, no. 2, pp. 191–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Thakur, M. T. Pritchard, M. R. McMullen, and L. E. Nagy, “Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 5, pp. G998–G1007, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Q. Rogers, J. M. Ajmo, and M. You, “Adiponectin and alcoholic fatty liver disease,” IUBMB Life, vol. 60, no. 12, pp. 790–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. T. Pritchard, M. R. McMullen, A. B. Stavitsky et al., “Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice,” Gastroenterology, vol. 132, no. 3, pp. 1117–1126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. K. Hyun, S. H. Eom, C. Y. Yu, and T. Roitsch, “Hovenia dulcis—an Asian traditional herb,” Planta Medica, vol. 76, no. 10, pp. 943–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Yao, K. Li, F. Song et al., “Heme oxygenase-1 upregulated by Ginkgo biloba extract: potential protection against ethanol-induced oxidative liver damage,” Food and Chemical Toxicology, vol. 45, no. 8, pp. 1333–1342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. I. J. I. Dela Peña, S. Y. Yoon, J. B. De La Peña et al., “The ameliorating effect of Rosa roxburghii against ethanol-induced psychomotor alterations in rats,” American Journal of Drug and Alcohol Abuse, vol. 40, no. 1, pp. 75–81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Lorke, “A new approach to practical acute toxicity testing,” Archives of Toxicology, vol. 54, no. 4, pp. 275–287, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Zeng, C.-L. Zhang, F.-Y. Song et al., “PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice,” Toxicology, vol. 296, no. 1–3, pp. 56–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Hopkins, “Network pharmacology: the next paradigm in drug discovery,” Nature Chemical Biology, vol. 4, no. 11, pp. 682–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R.-B. Ding, K. Tian, L.-L. Huang et al., “Herbal medicines for the prevention of alcoholic liver disease: a review,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 457–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-Q. Yin, Y.-C. Kim, Y.-S. Chung, Y.-C. Kim, Y.-K. Shin, and B.-H. Lee, “Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes,” Toxicology and Applied Pharmacology, vol. 236, no. 1, pp. 124–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K.-H. Chen, P.-C. Li, W.-H. Lin, C.-T. Chien, and B.-H. Low, “Depression by a green tea extract of alcohol-induced oxidative stress and lipogenesis in rat liver,” Bioscience, Biotechnology and Biochemistry, vol. 75, no. 9, pp. 1668–1676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Ajmo, X. Liang, C. Q. Rogers, B. Pennock, and M. You, “Resveratrol alleviates alcoholic fatty liver in mice,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 295, no. 4, pp. G833–G842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. V. Gnoni, G. Paglialonga, and L. Siculella, “Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells,” European Journal of Clinical Investigation, vol. 39, no. 9, pp. 761–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Mandal, M. T. Pritchard, and L. E. Nagy, “Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway,” World Journal of Gastroenterology, vol. 16, no. 11, pp. 1330–1336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Shehzad, W. Iqbal, O. Shehzad, and Y. S. Lee, “Adiponectin: regulation of its production and its role in human diseases,” Hormones, vol. 11, no. 1, pp. 8–20, 2012. View at Google Scholar · View at Scopus
  24. X. Chen, B. M. Sebastian, and L. E. Nagy, “Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 2, pp. E621–E628, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. R. Moschen, V. Wieser, and H. Tilg, “Adiponectin: key player in the adipose tissue-liver crosstalk,” Current Medicinal Chemistry, vol. 19, no. 32, pp. 5467–5473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Xu, Y. Wang, H. Keshaw, L. Y. Xu, K. S. L. Lam, and G. J. S. Cooper, “The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice,” The Journal of Clinical Investigation, vol. 112, no. 1, pp. 91–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. You, R. V. Considine, T. C. Leone, D. P. Kelly, and D. W. Crabb, “Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice,” Hepatology, vol. 42, no. 3, pp. 568–577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Marra and C. Bertolani, “A dipokines in liver diseases,” Hepatology, vol. 50, no. 3, pp. 957–969, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Ji, Q. Deng, and N. Kaplowitz, “Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury,” Hepatology, vol. 40, no. 2, pp. 442–451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Endo, T. Masaki, M. Seike, and H. Yoshimatsu, “TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protien-1c,” Experimental Biology and Medicine, vol. 232, no. 5, pp. 614–621, 2007. View at Google Scholar
  31. J. F. Lawler Jr., M. Yin, A. M. Diehl, E. Roberts, and S. Chatterjee, “Tumor necrosis factor-α stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase,” The Journal of Biological Chemistry, vol. 273, no. 9, pp. 5053–5059, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. J. García-Villafranca, A. Guillén, and J. Castro, “Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver,” Biochimie, vol. 90, no. 3, pp. 460–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Everitt, M. Hu, J. M. Ajmo et al., “Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 304, no. 1, pp. G38–G47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. L. Colombo and S. Moncada, “AMPKα1 regulates the antioxidant status of vascular endothelial cells,” Biochemical Journal, vol. 421, no. 2, pp. 163–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Song and M.-H. Zou, “Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems,” Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1607–1619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Bergheim, L. Guo, M. A. Davis et al., “Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1,” Gastroenterology, vol. 130, no. 7, pp. 2099–2112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Xu, K. K. Y. Lai, A. Verlinsky et al., “Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK,” Journal of Hepatology, vol. 55, no. 3, pp. 673–682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Heald and M. A. Cawthorne, “Dual acting and pan-PPAR activators as potential anti-diabetic therapies,” in Handbook of Experimental Pharmacology, vol. 203, pp. 35–51, 2011. View at Google Scholar
  39. J. Goldwasser, P. Y. Cohen, E. Yang, P. Balaguer, M. L. Yarmush, and Y. Nahmias, “Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARα, PPARγ and LXRα,” PLoS ONE, vol. 5, no. 8, Article ID e12399, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Song, R. R. Attia, S. Connaughton et al., “Peroxisome proliferator activated receptor α (PPARα) and PPAR gamma coactivator (PGC-1α) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements,” Molecular and Cellular Endocrinology, vol. 325, no. 1-2, pp. 54–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Ip, G. C. Farrell, G. Robertson, P. Hall, R. Kirsch, and I. Leclercq, “Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice,” Hepatology, vol. 38, no. 1, pp. 123–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Lebrun, O. Molendi-Coste, N. Lanthier et al., “Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice,” Clinical Science, vol. 125, no. 11, pp. 501–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. J. D. Horton, J. L. Goldstein, and M. S. Brown, “SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver,” Journal of Clinical Investigation, vol. 109, no. 9, pp. 1125–1131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Yahagi, H. Shimano, A. H. Hasty et al., “Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice,” The Journal of Biological Chemistry, vol. 277, no. 22, pp. 19353–19357, 2002. View at Publisher · View at Google Scholar · View at Scopus